Pharmaceutical companies face challenges when changes in labeling requirements, improperly labeled products, or sudden shortages in the market (due to production disruptions or increased demand). All this require modifications to the package leaflet, outer packaging, or repackaging of medicines intended for another markets. In such cases, it is crucial to receive fast and high quality services while avoiding costs sending medicines back to the factory. This way, both time and money are saved  – while maintaining the highest standards of safety and quality.

Since 2012, ENTAFARMA has been providing high-quality pharmaceutical repackaging services. The company specializes in the fields of import, batch release, repackaging, packaging, serialization and aggregation of medicinal products. ENTAFARMA offers fast, cost-effective solutions that comply with GMP standards and the requirements of the Falsified Medicines Directive (FMD), serving both pharmaceutical and veterinary medicine companies.

Starting with a single client, ENTAFARMA today collaborates with over 20 companies, including well-known local and international pharmaceutical manufacturers such as Astellas Pharma Europe, Fresenius Kabi, Johnson & Johnson, MSD, Novartis Consumer Health, Sandoz, Sanofi, Stada, Teva, and others. Successful audits and long-term partners trust confirm ENTAFARMA’s reputation as a reliable and high-quality service provider. Each year, ENTAFARMA repackages more than 6 million units of medicinal products, ensuring hight quality and full compliance with GMP standards.